BioNTech SE (BNTX)
112.82
-3.75
(-3.22%)
USD |
NASDAQ |
Aug 24, 16:00
113.17
+0.35
(+0.31%)
After-Hours: 20:00
BioNTech Total Liabilities (Quarterly) : 2.956B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.956B |
| March 31, 2026 | 2.738B |
| December 31, 2025 | 3.247B |
| September 30, 2025 | 3.365B |
| June 30, 2025 | 3.677B |
| March 31, 2025 | 2.437B |
| December 31, 2024 | 3.229B |
| September 30, 2024 | 3.668B |
| June 30, 2024 | 3.393B |
| March 31, 2024 | 2.472B |
| December 31, 2023 | 3.049B |
| September 30, 2023 | 2.478B |
| June 30, 2023 | 2.530B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.970B |
| December 31, 2022 | 3.440B |
| September 30, 2022 | 4.207B |
| June 30, 2022 | 4.521B |
| March 31, 2022 | 4.883B |
| December 31, 2021 | 4.477B |
| September 30, 2021 | 6.399B |
| June 30, 2021 | 4.348B |
| March 31, 2021 | 1.980B |
| December 31, 2020 | 1.158B |
| September 30, 2020 | 611.62M |
| June 30, 2020 | 417.26M |
| March 31, 2020 | 311.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 4.20B |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 6.062M |
| NuCana Plc | 7.330M |
| MediGene AG | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.26B |
| Shareholders Equity (Quarterly) | 20.30B |
| Debt to Equity Ratio | 0.0178 |
| Current Ratio | 7.848 |
| Net Debt Paydown Yield | -0.04% |